E-Book | November 21, 2022

Boost LNP Drug Potency With Optimized Delivery Formulations

Scientist In Lab GettyImages-1354172647

In medicine, the biggest hurdle is getting the active pharmaceutical ingredient (API) into the target cells at the disease site, referred to as the drug delivery challenge. Nucleic acid drugs in particular face many hurdles in their journey from vial to the cytoplasm of target cells where they are active. Hydrolysis, ubiquitous nucleases, the host’s immune system, trafficking within the body, cellular uptake and release into the cytoplasm all impact the safety and efficacy of nucleic acid drugs.

Lipid nanoparticles (LNPs) function as a drug delivery system (DDS) for nucleic acids as it protects the cargo from degradation and mediates a targeted, safe, and efficient intracellular delivery. Learn about biomedical applications of lipid nanoparticles (LNPs), anatomy of LNPs, formulation optimization, and LNP safety.

VIEW THE E-BOOK!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Biosimilar Development